Payer Notebook: AHIP takes issue with proposed rule giving coverage pathway for FDA-approved breakthrough devices

Healthcare Finance: America's Health Insurance Plans this week submitted comments to a Centers for Medicare and Medicaid Services' proposed rule on Medicare Coverage of Innovative Technology and Definition of "reasonable and necessary." The proposed rule would establish a new Medicare coverage pathway for Food and Drug Administration-approved breakthrough devices under which national Medicare coverage for both traditional fee-for-service Medicare and Medicare Advantage would begin on the same day as a breakthrough device receives FDA approval, and would last up to four years.

Read article

Share